Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study-Reference-Cited by-同舟云学术

Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study

Published:2009-08 Issue:8 Volume:31 Page:1747-1753
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Adachi Jonathan D.,Faraawi Rafat Y.,O’Mahony Michael F.J.,Nayar Arun,Massaad Rachid,Evans Judith K.,Yacik Carol

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference8 articles.

1. Vertebral fracture definition from population-based data: Preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos);Jackson;Osteoporos Int.,2000

2. Oral bisphosphonates and upper gastrointestinal tract problems: What is the evidence?;Cryer;Mayo Clin Proc.,2002

3. Disintegration and esophageal irritation profiles of alendronate formulations: Implications for clinical safety and efficacy;Epstein;J Appl Res.,2005

4. The clinical tolerability profile of alendronate;Watts;Int J Clin Pract Suppl.,1999

5. Upper gastrointestinal and overall tolerability of alendronate once weekly in patients with osteoporosis: Results of a randomized, double-blind, placebo-controlled study [published correction appears in Curr Med Res Opin. 2004;20:575];Eisman;Curr Med Res Opin,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials;BMJ;2023-05-02

2. The problem of low adherence to antiresorptive therapy with bisphosphonates: solutions;Meditsinskiy sovet = Medical Council;2022-01-06

3. Investigating the Preventive Effects of 99Tc-Methylenediphosphonate on a Glucocorticoid-Induced Osteoporosis Rabbit Model;Current Topics in Medicinal Chemistry;2021-12-01

4. Esophageal Disease in Older Patients;The Esophagus;2021-04-30

5. Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials;Frontiers in Endocrinology;2020-11-10